Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Breaking the Global Scientific Supremacy through Open Access Journals

OMICS International
Posted on: 21 Nov 16

PR Newswire

LOS ANGELES, Nov. 21, 2016

LOS ANGELES, Nov. 21, 2016 /PRNewswire/ -- Dr. Srinubabu Gedela, CEO, OMICS International, said, open access journals are all set to break the supremacy over the global information and scientific research in order to quell the knowledge gap.

Although the Global Research and development expenditure is reaching two trillion dollars (US$), the research outcome is not attaining limelight due to the closed access publication models. It is out of reach to research community and tax payers, as they remained inaccessible. Genuine and quality oriented research outcome must be published in the open access journals in order to harness the benefits before the research get obsolete.

Global R&D spending region wise, asian countries share (China, Japan, India and South Korea) an increased total of 40% while South and North American share is decreasing to 30% from 35%. European R&D estimated expenditure is at 20% and 10% from rest of the world. China is expected to overtake Europe and United States in terms of R&D budget by 2020. As per GDP, Israel and Korea are the biggest spenders on R&D at 4.21% and 4.15% followed by Japan (3.49%), Finland(3.32%) and Sweden (3.12%).

The global industry and academic funding reveals the United States share as $514 billion followed by, China($397), Japan($167), Germany($109), South Korea($77) and India($72). Over the years, even though the funding from the Asian countries is on rise, their quality research results are not visible to the rest of the world. The articles originated from these countries are not getting cited frequently compared to the English speaking countries. "Probably this is due to limited reach or the inability of the non-English speaking world to articulate the same in English. The dominance of English in R&D is hindering many Asian and African scientists and open access journals could bridge these language barriers," Gedela added.

About: OMICS International with its 2000+ employees has been a pioneer in the dissemination of scientific information on healthcare through open access. With the help of 50000+ well-qualified scientists as editorial board members OMICS Group is able to grow from 10 journals in 2009 to 700 peer reviewed journals by 2016 with an increased reader base of 30 million. OMICS International's ConferenceSeries.com hosts 3000+ global annual meetings and celebrating November, an academic writing month.

CONTACT: ceo@omicsgroup.org

Logo - http://photos.prnewswire.com/prnh/20161023/431540LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/breaking-the-global-scientific-supremacy-through-open-access-journals-300366503.html

SOURCE OMICS International

PR Newswire
www.prnewswire.com

Last updated on: 21/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.